Public Safety Notification On Exosome Products

On December 6, 2019, the U.S. Food and Drug Administration (FDA) released a public safety notice on exosome products due to multiple reports of serious adverse effects experienced by individuals in Nebraska who were treated with unapproved products marketed as containing exosomes. The public safety notice asserts that there are currently no FDA-approved exosome products and clinics offering such products outside of FDA's review process are taking advantage of consumers and pose significant harm . . .